首页> 美国卫生研究院文献>AAPS PharmSciTech >Application of Carrier and Plasticizer to Improve the Dissolution and Bioavailability of Poorly Water-Soluble Baicalein by Hot Melt Extrusion
【2h】

Application of Carrier and Plasticizer to Improve the Dissolution and Bioavailability of Poorly Water-Soluble Baicalein by Hot Melt Extrusion

机译:载体和增塑剂通过热熔挤出改善水溶性较差的黄ical素的溶解度和生物利用度的应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The objective of this study was to develop a suitable formulation for baicalein (a poorly water-soluble drug exhibiting high melting point) to prepare solid dispersions using hot melt extrusion (HME). Proper carriers and plasticizers were selected by calculating the Hansen solubility parameters, evaluating melting processing condition, and measuring the solubility of obtained melts. The characteristic of solid dispersions prepared by HME was evaluated. The dissolution performance of the extrudates was compared to the pure drug and the physical mixtures. Physicochemical properties of the extrudates were characterized by differential scanning calorimetry (DSC), powder X-ray diffraction (PXRD), and Fourier transform infrared spectroscopy (FTIR). Relative bioavailability after oral administration in beagle dogs was assessed. As a result, Kollidon VA64 and Eudragit EPO were selected as two carriers; Cremophor RH was used as the plasticizer. The dissolution of all the extrudates was significantly improved. DSC and PXRD results suggested that baicalein in the extrudates was amorphous. FTIR spectroscopy revealed the interaction between drug and polymers. After oral administration, the relative bioavailability of solid dispersions with VA64 and EPO was comparative, about 2.4- and 2.9-fold greater compared to the pure drug, respectively.>Figure
机译:这项研究的目的是开发一种适用于黄ical素(水溶性差的药物,具有高熔点)的合适配方,以使用热熔挤出(HME)制备固体分散体。通过计算Hansen溶解度参数,评估熔融加工条件并测量所得熔体的溶解度来选择合适的载体和增塑剂。评价了由HME制备的固体分散体的特性。将挤出物的溶解性能与纯药物和物理混合物进行比较。通过差示扫描量热法(DSC),粉末X射线衍射(PXRD)和傅里叶变换红外光谱(FTIR)表征挤出物的理化性质。评估了比格犬口服后的相对生物利用度。结果,选择了Kollidon VA64和Eudragit EPO作为两个载体。 Cremophor RH被用作增塑剂。所有挤出物的溶解均得到显着改善。 DSC和PXRD结果表明挤出物中的黄ical素是无定形的。 FTIR光谱揭示了药物和聚合物之间的相互作用。口服后,具有VA64和EPO的固体分散体的相对生物利用度是可比较的,分别比纯药物高约2.4倍和2.9倍。<!-fig ft0-> <!-fig @ position = “ anchor”模式=文章f4-> <!-fig mode =“ anchred” f5-> > Figure <!-fig / graphic | fig / alternatives / graphic mode =“ anchored” m1-> <!-标题a7->ᅟ

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号